EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.1.3.56 | Breast Neoplasms |
28448505 |
Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells. |
diagnostic usage |
3 |
| 3.1.3.56 | Breast Neoplasms |
28448505 |
Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells. |
therapeutic application |
1 |
| 3.1.3.56 | Breast Neoplasms |
28448505 |
Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells. |
ongoing research |
3 |
| 3.1.3.56 | Breast Neoplasms |
28448505 |
Polyphenolic extract of InsP 5-ptase expressing tomato plants reduce the proliferation of MCF-7 breast cancer cells. |
unassigned |
0 |
| 3.1.3.56 | Carcinoma |
31437542 |
Prognostic Value of Inositol Polyphosphate-5-Phosphatase Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma. |
causal interaction |
4 |
| 3.1.3.56 | Carcinoma |
31437542 |
Prognostic Value of Inositol Polyphosphate-5-Phosphatase Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma. |
diagnostic usage |
4 |
| 3.1.3.56 | Carcinoma |
31437542 |
Prognostic Value of Inositol Polyphosphate-5-Phosphatase Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma. |
therapeutic application |
1 |
| 3.1.3.56 | Carcinoma |
25759212 |
A distinct and replicable variant of the squamous cell carcinoma gene inositol polyphosphate-5-phosphatase modifies the susceptibility of arsenic-associated skin lesions in Bangladesh. |
ongoing research |
1 |
| 3.1.3.56 | Carcinoma |
31437542 |
Prognostic Value of Inositol Polyphosphate-5-Phosphatase Expression in Recurrent and Metastatic Cutaneous Squamous Cell Carcinoma. |
ongoing research |
3 |
| 3.1.3.56 | Carcinoma |
19875416 |
Random DNA fragmentation allows detection of single-copy, single-exon alterations of copy number by oligonucleotide array CGH in clinical FFPE samples. |
ongoing research |
3 |
